Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.
As bird flu swept through Europe in 2023, the U.S. enacted import bans. In October 2023, France became the first major ...
Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...
CDC officials say medical professionals are seeing more patients whose illness cannot be traced back to an infected animal or ...
Moderna’s current price is less than $20 below the psychologically significant $50 price level. Traders often focus on these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback